M. Shtan, A. Ozornin, and N. Govorin, “Features Dyslipidemias Disorders in Patients With Schizophrenia Treated With Haloperidol and Risperidone, Depending on the Carrier State of Some Genetic Polymorphisms”, СТПР, no. 1, pp. 29–37, Mar. 2019.